Root Financial Partners
NPCE icon

Root Financial Partners’s Neuropace NPCE Stock Holding History

Root Financial Partners’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$867 Buy
+63
New +$934 ﹤0.01% 3014
2026
Q2 		– Sell
-33
Closed -$434 – 2211
2026
Q1 		$434 Buy
+33
New +$495 ﹤0.01% 2913

Other funds holding NPCE

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Hughes Financial Services
Hughes Financial Services Herndon, Virginia $786M AUM 13.15% 1-Year Est. Return

Root Financial Partners's NPCE Position: Q3 2026 in Review

Root Financial Partners opened a new position in Neuropace (NPCE) in Q3 2026: 63 shares worth $867. The stake represents ﹤0.01% of the portfolio and ranks #3014 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in NPCE as recently as Q1 2026.

Root Financial Partners first reported a position in NPCE in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Root Financial Partners held 63 shares of Neuropace worth $867 as of Q3 2026.
  • Neuropace was a new Root Financial Partners position in Q3 2026.
  • Neuropace made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3014 holding.
  • Root Financial Partners first reported a position in Neuropace in Q1 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.